Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
II CRT vs CSP – CONSYST-CRT
• Trial JACC EP https://doi.org/10.1016/j.jacep.2025.03.024
III The Important QRS
• Kewcharoen et al https://www.ahajournals.org/doi/10.1161/CIRCEP.125.013809
IV ABYSS Trial of BB Interruption after MI Continues to be Mis-interpreted
• ABYSS Main https://www.nejm.org/doi/full/10.1056/NEJMoa2404204
• ABYSS substudy https://doi.org/10.1093/eurheartj/ehaf170
• REDUCE AMI https://www.nejm.org/doi/full/10.1056/NEJMoa2401479
V Oral PCSK9i and the PURSUIT Trial
• Koren et al https://www.jacc.org/doi/10.1016/j.jacc.2025.03.499
• Editorial https://doi.org/10.1016/j.jacc.2025.03.518
• Is Lifelong LDL-C Lowering Within Reach? The heart-1 Gene-Editing Trial https://www.medscape.com/viewarticle/998162
• Heart-1 Gene Therapy Trial Pauses Enrollment https://www.medscape.com/viewarticle/998162
• EHJ coverage VERVE https://academic.oup.com/ehjcvp/article/10/2/87/7455877
VI Cardiac Sarcoidosis and Risk of VT
• EHJ paper Mathijssen et al https://doi.org/10.1093/eurheartj/ehaf338
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
